SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.39 |
| Enterprise Value ($M) | -0.97 |
| Book Value ($M) | 3.45 |
| Book Value / Share | 4.71 |
| Price / Book | 0.69 |
| NCAV ($M) | 3.22 |
| NCAV / Share | 4.39 |
| Price / NCAV | 0.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.23 |
| Return on Assets (ROA) | -6.69 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.44 |
| Current Ratio | 5.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.95 |
| Assets | 4.18 |
| Liabilities | 0.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 57,008 | 166,934 | 34.15 | |
| 68,209 | 181,446 | 37.59 | |
| 390,494 | 1,193,442 | 32.72 | |
| 54,762 | 158,637 | 34.52 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AKBA – Akebia Therapeutics, Inc. | ALDX – Aldeyra Therapeutics, Inc. |
| ALGS – Aligos Therapeutics, Inc. | ANEB – Anebulo Pharmaceuticals, Inc. |
| ANIX – Anixa Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io